Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.74 by 5.41 percent. This is a 16.42 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $1.741 billion which beat the analyst consensus estimate of $1.700 billion by 2.40 percent. This is a 13.64 percent increase over sales of $1.532 billion the same period last year.